ESR1 and breast cancer: Importantly, the ability of 27HC to stimulate the transcriptional activity of ERα leading to BC progression was highly dependent on the concentration of 17β-estradiol in the surroundings; 27HC mainly activated ERα in the absence of estrogen or under hypo-estrogenic conditions while it principally displayed antagonistic effects on ERα under normal to high estrogenic conditions [24–26].